Amidst the economic slowdown of China and US, the stocks of Germany have further impacted the world economy as its market today tumbled lower than expected. Before the news of Germany’s shares slopping down, the US dollar was doing quite well.
With hope of recovering the country from the financial crunch, the Fed decided to launch a “Operation Twist” program. The objective of the program was set at lowering the borrowing cost, as Fed believed by doing so the country could be relieved from the turbulent financial economy.
However, before the program could be launched, the Fed took a step back as it is feared that with launch of the program, global downturn will become difficult to be cured. The woes of the Fed were echoed by HSBC’s China Flash PMI when it revealed that because of the global financial turmoil, the economy of the developing countries was witnessing a contraction.
Now, questions are being raised as to whether the European crisis will ever be solved. The stocks on the European market are on continuous decline. It has been reported that in this year the European stocks has witnessed fall of 21%.
In a Tuesday announcement, Supergiant Games studio’s founder Greg Kasavin said that the studio — the creator of games like Bastion and Transistor — has plans underway to launch a new action-RPG in 2017.
According to the announcement,…
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies…
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel’s…
Electric vehicle manufacturer Tesla has said in a recent announcement that it is now offering free trials of its autopilot software on Model S and Model X cars. The free trials give the owners of Model S and Model X cars a chance to test…
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in…
On Tuesday, tech giant Google released latest to show how much of its online traffic is…
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won’t seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said…
In a Tuesday announcement, Adobe revealed that it has...
With the computer business having witnessed steep losses...
In a scenario where the government of the nations are...
After the event that was the 'hot-news' of the week, the...
© 2024 AustrianTribune